NorthWest Biotherapeutics Inc (NWBO)

[Lykiri]

Great find ATLnsider!
I find the way Sarah Owen phrases her questions quite revealing – she seems to assume that the MHRA has already made a decision on DCVax-L and that it's just a matter of making it public. Her second question doesn’t ask if there will be access via the NHS, but rather how quickly that access can be arranged. This strongly suggests a positive outcome is expected, IMO.

> 639 — To ask the Secretary of State for Health and Social Care, when he expects the Medicines and Healthcare products Regulatory Agency will make public their decision on licensing the personalised immunotherapy developed to treat the malignant brain tumour glioblastoma, DCVax-L.

> 640 — To ask the Secretary of State for Health and Social Care, whether his Department plans to work with the National Institute for Health and Care Excellence to expedite market access to the personalised immunotherapy developed to treat the malignant brain tumour glioblastoma DCVax-L via the NHS

.

Sarah Owen MP is an officer in the All-Party Parliamentary Group on Brain Tumours.
https://publications.parliament.uk/pa/cm/cmallparty/250328/brain-tumours.htm